Early relapse following initial therapy for multiple myeloma predicts poor outcomes in the era of novel agents-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Early relapse following initial therapy for multiple myeloma predicts poor outcomes in the era of novel agents

Published:2016-05-23 Issue:11 Volume:30 Page:2208-2213
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Majithia N,Rajkumar S V,Lacy M Q,Buadi F K,Dispenzieri A,Gertz M A,Hayman S R,Dingli D,Kapoor P,Hwa L,Lust J A,Russell S J,Go R S,Kyle R A,Kumar S K

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2016147.pdf

Reference23 articles.

1. Kumar SK, Therneau TM, Gertz MA, Lacy MQ, Dispenzieri A, Rajkumar SV et al. Clinical course of patients with relapsed multiple myeloma. Mayo Clin Proc 2004; 79: 867–874.

2. Drewinko B, Alexanian R, Boyer H, Barlogie B, Rubinow SI . The growth fraction of human myeloma cells. Blood 1981; 57: 333–338.

3. Riccardi A, Mora O, Tinelli C, Porta C, Danova M, Brugnatelli S et al. Response to first-line chemotherapy and long-term survival in patients with multiple myeloma: results of the MM87 prospective randomised protocol. Eur J Cancer 2003; 39: 31–37.

4. Durie BG, Jacobson J, Barlogie B, Crowley J . Magnitude of response with myeloma frontline therapy does not predict outcome: importance of time to progression in southwest oncology group chemotherapy trials. J Clin Oncol 2004; 22: 1857–1863.

5. Kumar S, Mahmood ST, Lacy MQ, Dispenzieri A, Hayman SR, Buadi FK et al. Impact of early relapse after auto-SCT for multiple myeloma. Bone Marrow Transplant 2008; 42: 413–420.

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of clinical‐biological features of newly diagnosed early relapse multiple myeloma patients eligible for autologous stem cell transplantation;eJHaem;2024-06-16

2. Navigating High-Risk and Ultrahigh-Risk Multiple Myeloma: Challenges and Emerging Strategies;American Society of Clinical Oncology Educational Book;2024-06

3. Circulating miR-16 and miR-21 Levels in Multiple Myeloma: Prognostic Significance of Survival and Response to Lenalidomide Treatment;International Journal of Molecular Sciences;2024-05-31

4. Development and Validation of a Prediction Model of Outcome After B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Multiple Myeloma;Journal of Clinical Oncology;2024-05-10

5. Mer receptor expression promotes multiple myeloma disease development via a cell-extrinsic mechanism;2024-04-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3